Copied to clipboard!
Validating ctDNA Observation vs. Routine Investigations (VICTORI) Study
VICTORI is an observational, prospective study exploring the use of the NeXT Personal ctDNA assay in exploring minimal residual disease (MRD) in patients with colorectal cancer following curative intent surgery. Whole-genome informed panels of ~1,800 variants were created for patients, and were used to interrogate plasma samples collected at baseline, and weeks 2, 4, 6 and 8 post-surgery as well as every 3 months on surveillance.
- Type: Cancer Genomics
- Archive: Canadian Genome-phenome Archive (CGA) Federated EGA Node
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD50000002987 | Illumina NovaSeq 6000 | 218 |
